Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Scrip Team

Latest From Scrip Team

Executives On The Move: CEOs Named At Elevation Oncology, PainReform Ltd

Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma

Appointments BioPharmaceutical

Coronavirus Update: Pfizer, BioNTech Hit Ground Running On Vaccine EUA

US FDA will hold 10 December advisory committee on Pfizer/BioNTech's just-filed application; the WHO issued a recommendation against Gilead's Veklury for hospitalized patients.

BioPharmaceutical Coronavirus COVID-19

Executives On The Move: New CEOs Named At Gossamer Bio, Liminal BioSciences

Board directors appointed at Athersys, Trillium Therapeutics and Viatris

Appointments BioPharmaceutical

Coronavirus Update: CureVac's EU Vaccine Deal, J&J's New Vaccine Study, BioNTech/Fosun Get China Go-Ahead

CureVac seals EU Deal for 405 million doses of CVnCoV, a second Phase III trial for J&J’s COVID-19 vaccine starts, and BioNTech, Fosun get OK for China vaccine trial.

Clinical Trials Companies

Coronavirus Update: Moderna Ready For Interim Analysis, Brazil Resumes SinoVac Trial

Moderna's vaccine has reached the requisite number of cases to trigger a Phase III interim analysis and Brazil allows SinoVac's trial to resume after a serious adverse event, but AstraZeneca's Calquence fails to show any benefit in hospitalized COVID-19 patients. Medicago and GSK also report vaccine progress and the RDIF strikes another production deal.

Coronavirus COVID-19 Clinical Trials

Executives On The Move: New CMOs Named At Agenus, Editas Medicine

Marinus Pharmaceuticals secures a new chief commercial officer, PledPharma names a new vice-president of commercial operations.

Appointments BioPharmaceutical
See All
UsernamePublicRestriction

Register